NCT01490749 Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer Status COMPLETED Phase PHASE1
NCT01486602 Specialized Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE1
NCT01478685 A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT01462890 Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer Status COMPLETED Phase PHASE3
NCT01462149 Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01461772 Efficacy and Safety Study of Concurrent Chemoradiation Therapy to Treat Locally Advanced Cervical Cancer Status TERMINATED Phase PHASE3
NCT01459380 Pegylated Liposomal Doxorubicin Hydrochloride, Carboplatin, Veliparib, and Bevacizumab in Treating Patients With Recurrent Ovarian Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer Status COMPLETED Phase PHASE1
NCT01458366 Phase I/II Study of Bendamustine in Combination With Ofatumumab, Carboplatin and Etoposide Status COMPLETED Phase PHASE1/PHASE2
NCT01455532 A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors Status COMPLETED Phase PHASE1
NCT01454102 Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) Status COMPLETED Phase PHASE1
NCT01454089 A Phase 2 Study Comparing Chemotherapy in Combination With OGX-427 or Placebo in Patients With Bladder Cancer Status COMPLETED Phase PHASE2
NCT01450761 Trial in Extensive-Disease Small Cell Lung Cancer (ED-SCLC) Subjects Comparing Ipilimumab Plus Etoposide and Platinum Therapy to Etoposide and Platinum Therapy Alone Status COMPLETED Phase PHASE3
NCT01447225 Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT01445119 A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas Status COMPLETED Phase PHASE1
NCT01443078 Neoadjuvant Platinum-based Chemotherapy for Patients With Resectable , Non-small Cell Lung Cancer With Switch to Chemotherapy Alternative in Nonresponders (NEOSCAN) Status COMPLETED Phase PHASE2
NCT01440998 Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer Status COMPLETED Phase PHASE1
NCT01439568 A Study of LY2510924 in Participants With Extensive-Stage Small Cell Lung Carcinoma Status COMPLETED Phase PHASE2
NCT01437449 Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Status COMPLETED Phase PHASE2
NCT01428414 Efficacy and Safety Study of Trastuzumab and Paclitaxel Based Regimens to Treat HER2-positive Breast Cancer Status UNKNOWN Phase PHASE2
NCT01426880 Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer Status COMPLETED Phase PHASE2/PHASE3